[Clinical and experimental studies of DBED-Penicilline in bacterial airway-infections in children].
Serum concentrations and therapeutic effects of DBED-Penicilline was checked in 22 resp. 26 children, 1-14 years of age. 15 min up to 2 hours and more following oral application of DBED-Penicilline a bactericide serum level was observed. The clinical effectiveness of orally administered DBED-Penicilline was proved in airway-infections of children. The flavor of the drug was well accepted.
D000293:Adolescent; D000367:Age Factors; D001424:Bacterial Infections / Q000188:drug therapy*; D001682:Biological Availability; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006801:Humans; D007223:Infant; D010033:Otitis Media / Q000188:drug therapy; D010404:Penicillin V / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012996:Solutions
D012996:Solutions; D010404:Penicillin V
DBED-Penicillin V (Ospen) bei bakteriellen Luftweginfektionen im Kindesalter. Klinisch-experimentelle Prüfung